首页|期刊导航|中华医学杂志（英文版）|Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
中华医学杂志（英文版）2020，Vol.133Issue(9)：1051-1056,6.DOI:10.1097/CM9.0000000000000797
Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
摘要
关键词
Coronavirus disease 2019/2019-Novel coronavirus/Cepharanthine/Selamectin/Mefloquine hydrochlorideKey words
Coronavirus disease 2019/2019-Novel coronavirus/Cepharanthine/Selamectin/Mefloquine hydrochloride引用本文复制引用
Hua-Hao Fan,Li-Qin Wang,Wen-Li Liu,Xiao-Ping An,Zhen-Dong Liu,Xiao-Qi He,Li-Hua Song,Yi-Gang Tong..Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model[J].中华医学杂志（英文版）,2020,133(9):1051-1056,6.基金项目
This work was supported by a project from Ministry of Science and Technology of China (No.2020YFC0840805),Key Project of Beijing University of Chemical Technology (No.XK1803-06),Fundamental Research Funds for Central Universities (No.BUCTRC201917),and a.start-up funding for Dr.Yi-Gang Tong from Beijing Advanced Innovation Center for Soft Matter Science and Engineering. （No.2020YFC0840805）
